ibuprofen has been researched along with Breast Cancer in 33 studies
Midol: combination of cinnamedrine, phenacetin, aspirin & caffeine
| Excerpt | Relevance | Reference |
|---|---|---|
| "Aspirin, nonsteroidal anti-inflammatory drugs (NSAIDs), and selective COX-2 inhibitors may improve outcomes in breast cancer patients." | 7.83 | Low-dose Aspirin, Nonsteroidal Anti-inflammatory Drugs, Selective COX-2 Inhibitors and Breast Cancer Recurrence. ( Ahern, TP; Christiansen, P; Cronin-Fenton, DP; Ejlertsen, B; Heide-Jørgensen, U; Lash, TL; Sørensen, HT, 2016) |
| "The purpose of this study was to investigate if ibuprofen intake can influence mammary uptake of the proliferation-seeking radiotracer technetium 99m-pentavalent dimercaptosuccinic acid (99mTc-(V)DMSA) in women with severe epithelial and atypical epithelial breast hyperplasia." | 7.76 | Ibuprofen induces reduction of the proliferation-seeking radiotracer 99mTc-(V)DMSA uptake in severe epithelial breast hyperplasia without atypia. ( Antsaklis, A; Archontaki, A; Dimitrakakis, K; Fothiadaki, A; Karianos, T; Marinopoulos, S; Papantoniou, V; Sotiropoulou, E; Sotiropoulou, M; Syrgiannis, K; Tsaroucha, A; Tsiouris, S; Valsamaki, P, 2010) |
| " Herein, the impacts of metformin alone and in combination with cimetidine/ibuprofen on some Th1- and regulatory T (Treg) cell-related parameters were evaluated using a breast cancer (BC) model." | 5.62 | Modulatory Effects of Metformin Alone and in Combination with Cimetidine and Ibuprofen on T Cell-related Parameters in a Breast Cancer Model. ( Hassan, ZM; Jafarzadeh, A; Khorramdelazad, H; Masoumi, J; Nemati, M; Oladpour, O; Rezayati, MT; Taghipour, F; Taghipour, Z, 2021) |
| "Ibuprofen was not effective in the comet assay but showed a significant reduction in MN frequency, with the nano formulation being more effective." | 5.48 | Aspirin and ibuprofen, in bulk and nanoforms: Effects on DNA damage in peripheral lymphocytes from breast cancer patients and healthy individuals. ( Anderson, D; Baumgartner, A; Dandah, O; Isreb, M; Linforth, R; Najafzadeh, M; Tait, C, 2018) |
| "Women diagnosed with breast cancer within 5 years postpartum (PPBC) have poorer prognosis than age matched nulliparous women, even after controlling for clinical variables known to impact disease outcomes." | 5.48 | Ibuprofen supports macrophage differentiation, T cell recruitment, and tumor suppression in a model of postpartum breast cancer. ( Betts, CB; Borges, VF; Coussens, LM; Guo, Q; Jindal, S; Martinson, HA; Pennock, ND; Schedin, P; Tsujikawa, T, 2018) |
| "P-I is safe and effective against breast cancer." | 5.38 | Phospho-ibuprofen (MDC-917) suppresses breast cancer growth: an effect controlled by the thioredoxin system. ( Huang, L; Komninou, D; Mackenzie, GG; Rigas, B; Rowehl, LM; Sun, Y; Vrankova, K, 2012) |
| "Studies that examined the association between risk of breast cancer and use of NSAIDs, including aspirin and ibuprofen, that were published between January 1, 1966, and July 1, 2008, were identified using Medline, EMBASE, and other databases." | 4.84 | Breast cancer and use of nonsteroidal anti-inflammatory drugs: a meta-analysis. ( Etminan, M; Regueira-Méndez, C; Takkouche, B, 2008) |
| "Aspirin, nonsteroidal anti-inflammatory drugs (NSAIDs), and selective COX-2 inhibitors may improve outcomes in breast cancer patients." | 3.83 | Low-dose Aspirin, Nonsteroidal Anti-inflammatory Drugs, Selective COX-2 Inhibitors and Breast Cancer Recurrence. ( Ahern, TP; Christiansen, P; Cronin-Fenton, DP; Ejlertsen, B; Heide-Jørgensen, U; Lash, TL; Sørensen, HT, 2016) |
| " To overcome this issue, in this work we synthesized biocompatible micellar nanocarriers composed of amphiphilic chitosan to deliver ibuprofen into breast cancer cells and evaluate its anti-tumor activity, while avoiding side-effects." | 3.80 | Synthesis and characterization of micelles as carriers of non-steroidal anti-inflammatory drugs (NSAID) for application in breast cancer therapy. ( Correia, IJ; Costa, E; Gaspar, VM; Marques, JG; Paquete, CM, 2014) |
| "The purpose of this study was to investigate if ibuprofen intake can influence mammary uptake of the proliferation-seeking radiotracer technetium 99m-pentavalent dimercaptosuccinic acid (99mTc-(V)DMSA) in women with severe epithelial and atypical epithelial breast hyperplasia." | 3.76 | Ibuprofen induces reduction of the proliferation-seeking radiotracer 99mTc-(V)DMSA uptake in severe epithelial breast hyperplasia without atypia. ( Antsaklis, A; Archontaki, A; Dimitrakakis, K; Fothiadaki, A; Karianos, T; Marinopoulos, S; Papantoniou, V; Sotiropoulou, E; Sotiropoulou, M; Syrgiannis, K; Tsaroucha, A; Tsiouris, S; Valsamaki, P, 2010) |
| "From 2000 to 2002, mailed questionnaires were used to obtain information on aspirin, ibuprofen, and other NSAID use and subsequent breast cancer events." | 3.74 | NSAIDs and breast cancer recurrence in a prospective cohort study. ( Caan, B; Habel, LA; Kwan, ML; Slattery, ML, 2007) |
| "Epidemiologic studies of the association between nonsteroidal anti-inflammatory drugs (NSAIDs), such as aspirin and ibuprofen, and breast cancer risk have yielded inconsistent results." | 3.73 | Nonsteroidal anti-inflammatory drug use and breast cancer risk by stage and hormone receptor status. ( Anton-Culver, H; Bernstein, L; Deapen, D; Horn-Ross, PL; Marshall, SF; Mohrenweiser, H; Peel, D; Pinder, R; Purdie, DM; Reynolds, P; Ross, RK; Stram, D; West, D; Wright, WE; Ziogas, A, 2005) |
| "We analyzed data from the prospective Women's Health Initiative (WHI) Observational Study to examine the effects of regular use of aspirin, ibuprofen, and other nonsteroidal anti-inflammatory drugs (NSAIDs) on breast cancer risk." | 3.72 | Breast cancer and nonsteroidal anti-inflammatory drugs: prospective results from the Women's Health Initiative. ( Anderson, G; Ascenseo, JL; Chlebowski, RT; Frid, DJ; Harris, RE; Jackson, RD; Loar, A; McTiernan, A; Rodabough, RJ; White, E, 2003) |
| "Previous studies have shown that the prostaglandin synthesis inhibitor indomethacin reduced osteolysis produced by the experimental VX2 carcinoma, probably by inhibiting the stimulation of osteoclasts by prostaglandin E2." | 3.66 | The effect of prostaglandin synthesis inhibitors and diphosphonates on tumour-mediated osteolysis. ( Galasko, CS; Lacey, E; Rushton, S; Samuel, AW, 1980) |
| "In addition to providing acute postoperative pain relief, preoperative PVB seems to reduce the prevalence of chronic pain 1 yr after breast cancer surgery." | 2.72 | Preincisional paravertebral block reduces the prevalence of chronic pain after breast surgery. ( Bachmann, MS; Kairaluoma, PM; Pere, PJ; Rosenberg, PH, 2006) |
| "A slight reduction of breast cancer by taking aspirin and ibuprofen was both observed with pooled RR of 0." | 2.45 | Association between NSAIDs use and breast cancer risk: a systematic review and meta-analysis. ( Hu, FL; Li, DD; Li, X; Li, XW; Wang, F; Zhang, WC; Zhao, YS; Zhu, S, 2009) |
| " Herein, the impacts of metformin alone and in combination with cimetidine/ibuprofen on some Th1- and regulatory T (Treg) cell-related parameters were evaluated using a breast cancer (BC) model." | 1.62 | Modulatory Effects of Metformin Alone and in Combination with Cimetidine and Ibuprofen on T Cell-related Parameters in a Breast Cancer Model. ( Hassan, ZM; Jafarzadeh, A; Khorramdelazad, H; Masoumi, J; Nemati, M; Oladpour, O; Rezayati, MT; Taghipour, F; Taghipour, Z, 2021) |
| "Ibuprofen was not effective in the comet assay but showed a significant reduction in MN frequency, with the nano formulation being more effective." | 1.48 | Aspirin and ibuprofen, in bulk and nanoforms: Effects on DNA damage in peripheral lymphocytes from breast cancer patients and healthy individuals. ( Anderson, D; Baumgartner, A; Dandah, O; Isreb, M; Linforth, R; Najafzadeh, M; Tait, C, 2018) |
| "Women diagnosed with breast cancer within 5 years postpartum (PPBC) have poorer prognosis than age matched nulliparous women, even after controlling for clinical variables known to impact disease outcomes." | 1.48 | Ibuprofen supports macrophage differentiation, T cell recruitment, and tumor suppression in a model of postpartum breast cancer. ( Betts, CB; Borges, VF; Coussens, LM; Guo, Q; Jindal, S; Martinson, HA; Pennock, ND; Schedin, P; Tsujikawa, T, 2018) |
| "P-I is safe and effective against breast cancer." | 1.38 | Phospho-ibuprofen (MDC-917) suppresses breast cancer growth: an effect controlled by the thioredoxin system. ( Huang, L; Komninou, D; Mackenzie, GG; Rigas, B; Rowehl, LM; Sun, Y; Vrankova, K, 2012) |
| "The prognosis of breast cancer in young women is influenced by reproductive history." | 1.37 | Postpartum mammary gland involution drives progression of ductal carcinoma in situ through collagen and COX-2. ( Borges, VF; Conklin, MW; Eliceiri, KW; Keely, PJ; Lyons, TR; Marusyk, A; O'Brien, J; Schedin, P; Tan, AC, 2011) |
| "and compound 7c exhibit good anticancer activity against ovary (IGR-OV-1), breast (MCF-7) and CNS(SF-295) human cancer cell lines." | 1.36 | Solvent free synthesis, anti-inflammatory and anticancer activity evaluation of tricyclic and tetracyclic benzimidazole derivatives. ( Agrawal, SK; Rani, R; Roy, P; Saxena, AK; Singh, J; Sondhi, SM, 2010) |
| "The relative risk of breast cancer was reduced in women using these compounds at least 3 times per week for > or = 1 year [odds ratio (OR) = 0." | 1.29 | Nonsteroidal antiinflammatory drugs and breast cancer. ( Farrar, WB; Harris, RE; Namboodiri, KK, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (6.06) | 18.7374 |
| 1990's | 2 (6.06) | 18.2507 |
| 2000's | 8 (24.24) | 29.6817 |
| 2010's | 17 (51.52) | 24.3611 |
| 2020's | 4 (12.12) | 2.80 |
| Authors | Studies |
|---|---|
| Sondhi, SM | 1 |
| Rani, R | 1 |
| Singh, J | 1 |
| Roy, P | 1 |
| Agrawal, SK | 1 |
| Saxena, AK | 1 |
| Liu, W | 2 |
| Zhou, J | 2 |
| Bensdorf, K | 1 |
| Zhang, H | 2 |
| Liu, H | 1 |
| Wang, Y | 2 |
| Qian, H | 2 |
| Zhang, Y | 1 |
| Wellner, A | 1 |
| Rubner, G | 1 |
| Huang, W | 2 |
| Guo, C | 1 |
| Gust, R | 3 |
| Zhang, T | 1 |
| Zhu, H | 1 |
| Taghipour, F | 1 |
| Oladpour, O | 1 |
| Rezayati, MT | 1 |
| Khorramdelazad, H | 1 |
| Nemati, M | 1 |
| Taghipour, Z | 1 |
| Masoumi, J | 1 |
| Hassan, ZM | 1 |
| Jafarzadeh, A | 1 |
| Predarska, I | 1 |
| Saoud, M | 1 |
| Morgan, I | 1 |
| Eichhorn, T | 1 |
| Kaluđerović, GN | 1 |
| Hey-Hawkins, E | 1 |
| Thiruchenthooran, V | 1 |
| Świtalska, M | 1 |
| Bonilla, L | 1 |
| Espina, M | 1 |
| García, ML | 1 |
| Wietrzyk, J | 1 |
| Sánchez-López, E | 1 |
| Gliszczyńska, A | 1 |
| Chai, Z | 1 |
| Teng, C | 1 |
| Yang, L | 1 |
| Ren, L | 1 |
| Yuan, Z | 1 |
| Xu, S | 1 |
| Cheng, M | 1 |
| Yan, Z | 1 |
| Qin, C | 1 |
| Han, X | 1 |
| Yin, L | 1 |
| Tran, BN | 1 |
| Nguyen, HT | 1 |
| Kim, JO | 1 |
| Yong, CS | 1 |
| Nguyen, CN | 1 |
| Dandah, O | 1 |
| Najafzadeh, M | 1 |
| Isreb, M | 1 |
| Linforth, R | 1 |
| Tait, C | 1 |
| Baumgartner, A | 1 |
| Anderson, D | 1 |
| Sahin, A | 1 |
| Spiroux, F | 1 |
| Guedon, I | 1 |
| Arslan, FB | 1 |
| Sarcan, ET | 1 |
| Ozkan, T | 1 |
| Colak, N | 1 |
| Yuksel, S | 1 |
| Ozdemir, S | 1 |
| Ozdemir, B | 1 |
| Akbas, S | 1 |
| Ultav, G | 1 |
| Aktas, Y | 1 |
| Capan, Y | 1 |
| Pennock, ND | 1 |
| Martinson, HA | 1 |
| Guo, Q | 1 |
| Betts, CB | 1 |
| Jindal, S | 1 |
| Tsujikawa, T | 1 |
| Coussens, LM | 1 |
| Borges, VF | 2 |
| Schedin, P | 2 |
| Marques, JG | 1 |
| Gaspar, VM | 1 |
| Costa, E | 1 |
| Paquete, CM | 1 |
| Correia, IJ | 1 |
| Cronin-Fenton, DP | 1 |
| Heide-Jørgensen, U | 1 |
| Ahern, TP | 1 |
| Lash, TL | 1 |
| Christiansen, P | 1 |
| Ejlertsen, B | 1 |
| Sørensen, HT | 1 |
| Kopp, TI | 1 |
| Jensen, DM | 1 |
| Ravn-Haren, G | 1 |
| Cohen, A | 1 |
| Sommer, HM | 1 |
| Dragsted, LO | 1 |
| Tjonneland, A | 1 |
| Hougaard, DM | 1 |
| Vogel, U | 1 |
| Takkouche, B | 1 |
| Regueira-Méndez, C | 1 |
| Etminan, M | 1 |
| Zhao, YS | 1 |
| Zhu, S | 1 |
| Li, XW | 1 |
| Wang, F | 1 |
| Hu, FL | 1 |
| Li, DD | 1 |
| Zhang, WC | 1 |
| Li, X | 1 |
| Brasky, TM | 2 |
| Bonner, MR | 2 |
| Moysich, KB | 2 |
| Ochs-Balcom, HM | 1 |
| Marian, C | 2 |
| Ambrosone, CB | 2 |
| Nie, J | 2 |
| Tao, MH | 2 |
| Edge, SB | 2 |
| Trevisan, M | 2 |
| Shields, PG | 2 |
| Freudenheim, JL | 2 |
| Papantoniou, V | 1 |
| Tsaroucha, A | 1 |
| Valsamaki, P | 1 |
| Tsiouris, S | 1 |
| Sotiropoulou, E | 1 |
| Karianos, T | 1 |
| Marinopoulos, S | 1 |
| Fothiadaki, A | 1 |
| Sotiropoulou, M | 1 |
| Archontaki, A | 1 |
| Syrgiannis, K | 1 |
| Dimitrakakis, K | 1 |
| Antsaklis, A | 1 |
| Kallakury, BV | 1 |
| Goerlitz, DS | 1 |
| Lyons, TR | 1 |
| O'Brien, J | 1 |
| Conklin, MW | 1 |
| Keely, PJ | 1 |
| Eliceiri, KW | 1 |
| Marusyk, A | 1 |
| Tan, AC | 1 |
| Mattheolabakis, G | 1 |
| Nie, T | 1 |
| Constantinides, PP | 1 |
| Rigas, B | 2 |
| Sun, Y | 1 |
| Rowehl, LM | 1 |
| Huang, L | 1 |
| Mackenzie, GG | 1 |
| Vrankova, K | 1 |
| Komninou, D | 1 |
| Mitchell, A | 1 |
| McCrea, P | 1 |
| Inglis, K | 1 |
| Porter, G | 1 |
| Robb-Nicholson, C | 1 |
| Harris, RE | 2 |
| Chlebowski, RT | 1 |
| Jackson, RD | 1 |
| Frid, DJ | 1 |
| Ascenseo, JL | 1 |
| Anderson, G | 1 |
| Loar, A | 1 |
| Rodabough, RJ | 1 |
| White, E | 1 |
| McTiernan, A | 1 |
| Marshall, SF | 1 |
| Bernstein, L | 1 |
| Anton-Culver, H | 1 |
| Deapen, D | 1 |
| Horn-Ross, PL | 1 |
| Mohrenweiser, H | 1 |
| Peel, D | 1 |
| Pinder, R | 1 |
| Purdie, DM | 1 |
| Reynolds, P | 1 |
| Stram, D | 1 |
| West, D | 1 |
| Wright, WE | 1 |
| Ziogas, A | 1 |
| Ross, RK | 1 |
| Kairaluoma, PM | 1 |
| Bachmann, MS | 1 |
| Rosenberg, PH | 1 |
| Pere, PJ | 1 |
| Banekovich, C | 1 |
| Ott, I | 1 |
| Koch, T | 1 |
| Matuszczak, B | 1 |
| Kwan, ML | 1 |
| Habel, LA | 1 |
| Slattery, ML | 1 |
| Caan, B | 1 |
| Galasko, CS | 1 |
| Samuel, AW | 1 |
| Rushton, S | 1 |
| Lacey, E | 1 |
| Namboodiri, KK | 1 |
| Farrar, WB | 1 |
| Cameron, DJ | 1 |
| O'Brien, P | 1 |
| Majeski, JA | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Alcohol-related Breast Cancer in Postmenopausal Women - Effect of PPARG2pro12ala Polymorphism on Female Sex-hormone Levels and Interaction With Alcohol Consumption and NSAID Usage[NCT02463383] | Early Phase 1 | 25 participants (Actual) | Interventional | 2013-09-30 | Completed | ||
| Post-operative Analgesia in Elective, Soft-tissue Hand Surgery: A Randomized, Double Blind Comparison of Acetaminophen/Ibuprofen Versus Acetaminophen/Hydrocodone[NCT02029235] | Phase 4 | 72 participants (Actual) | Interventional | 2015-02-10 | Terminated (stopped due to Early termination due to slower than anticipated recruitment.) | ||
| [NCT00000611] | Phase 3 | 0 participants | Interventional | Completed | |||
| Analgesia Efficacy of Pre-operative and Post-operative PEC I/II Block for Bilateral Mastectomy With Reconstruction[NCT03653988] | 35 participants (Actual) | Interventional | 2019-03-12 | Completed | |||
| Comparison Between Serratus Anterior Plane Block, and Transversus Thoracic Plane Block Combined With Serratus Anterior Plane Block, for the Management of Post-mastecomy Pain.[NCT04375111] | 54 participants (Actual) | Interventional | 2021-06-15 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
"Subjects asked to fill out a patient diary recording their pain intensity level (on 100mm Visual Analog Scale) prior to taking study medication every 4 hours.~The daily average pain intensity levels are reported as a score on a scale of 0-100, with higher score meaning worse outcome.~The daily average pain levels were assessed daily for 1 week post-operatively, then compared between the 2 groups using a two-group Student's t-test." (NCT02029235)
Timeframe: 1 week post-operatively
| Intervention | score on a scale (0-100, higher = worse) (Mean) | ||||||
|---|---|---|---|---|---|---|---|
| Daily average pain intensity level on PostOp Day 1 | Daily average pain intensity level on PostOp Day 2 | Daily average pain intensity level on PostOp Day 3 | Daily average pain intensity levelon PostOp Day 4 | Daily average pain intensity level on PostOp Day 5 | Daily average pain intensity level on PostOp Day 6 | Daily average pain intensity level on PostOp Day 7 | |
| Acetaminophen/Hydrocodone (AH) Group | 24.07 | 30.16 | 22.11 | 18.53 | 16.61 | 13.58 | 13.00 |
| Acetaminophen/Ibuprofen (AIBU) Group | 22.17 | 22.22 | 15.67 | 13.17 | 14.03 | 13.44 | 12.67 |
"Subjects asked to fill out a patient diary recording their pain relief (on a Likert scale) one hour after taking study medication every 4 hours.~Daily average pain relief scores are reported as a score on a scale of 0-3, with higher score meaning better outcome.~The daily average pain relief scores were assessed daily for 1 week post-operatively, then compared using generalized linear mixed-effects models" (NCT02029235)
Timeframe: 1 week postoperatively
| Intervention | score on a scale (0-3, higher = better) (Mean) | ||||||
|---|---|---|---|---|---|---|---|
| Daily average pain relief on PostOp Day 1 | Daily average pain relief on PostOp Day 2 | Daily average pain relief on PostOp Day 3 | Daily average pain relief on PostOp Day 4 | Daily average pain relief on PostOp Day 5 | Daily average pain relief on PostOp Day 6 | Daily average pain relief on PostOp Day 7 | |
| Acetaminophen/Hydrocodone (AH) Group | 1.53 | 1.76 | 2.33 | 2.46 | 2.54 | 2.84 | 2.88 |
| Acetaminophen/Ibuprofen (AIBU) Group | 1.84 | 2.27 | 2.63 | 2.91 | 2.88 | 2.87 | 2.96 |
2 reviews available for ibuprofen and Breast Cancer
| Article | Year |
|---|---|
Breast cancer and use of nonsteroidal anti-inflammatory drugs: a meta-analysis.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Breast Neoplasms; Case-Control Studies; Cohort Stu | 2008 |
Association between NSAIDs use and breast cancer risk: a systematic review and meta-analysis.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Breast Neoplasms; Female; Humans; Ibuprofen; Risk | 2009 |
4 trials available for ibuprofen and Breast Cancer
| Article | Year |
|---|---|
Alcohol-related breast cancer in postmenopausal women - effect of CYP19A1, PPARG and PPARGC1A polymorphisms on female sex-hormone levels and interaction with alcohol consumption and NSAID usage in a nested case-control study and a randomised controlled tr
Topics: Adult; Alcohol Drinking; Alcohols; Anti-Inflammatory Agents, Non-Steroidal; Aromatase; Breast Neopla | 2016 |
Genetic variants in COX-2, non-steroidal anti-inflammatory drugs, and breast cancer risk: the Western New York Exposures and Breast Cancer (WEB) Study.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Breast; Breast Neoplasms; Case-Contro | 2011 |
A randomized, controlled trial comparing acetaminophen plus ibuprofen versus acetaminophen plus codeine plus caffeine (Tylenol 3) after outpatient breast surgery.
Topics: Acetaminophen; Adult; Ambulatory Surgical Procedures; Analgesics, Non-Narcotic; Breast Neoplasms; Ca | 2012 |
Preincisional paravertebral block reduces the prevalence of chronic pain after breast surgery.
Topics: Acetaminophen; Analgesia, Epidural; Breast Neoplasms; Bupivacaine; Codeine; Follow-Up Studies; Human | 2006 |
Preincisional paravertebral block reduces the prevalence of chronic pain after breast surgery.
Topics: Acetaminophen; Analgesia, Epidural; Breast Neoplasms; Bupivacaine; Codeine; Follow-Up Studies; Human | 2006 |
Preincisional paravertebral block reduces the prevalence of chronic pain after breast surgery.
Topics: Acetaminophen; Analgesia, Epidural; Breast Neoplasms; Bupivacaine; Codeine; Follow-Up Studies; Human | 2006 |
Preincisional paravertebral block reduces the prevalence of chronic pain after breast surgery.
Topics: Acetaminophen; Analgesia, Epidural; Breast Neoplasms; Bupivacaine; Codeine; Follow-Up Studies; Human | 2006 |
27 other studies available for ibuprofen and Breast Cancer
| Article | Year |
|---|---|
Solvent free synthesis, anti-inflammatory and anticancer activity evaluation of tricyclic and tetracyclic benzimidazole derivatives.
Topics: Anti-Inflammatory Agents; Antineoplastic Agents; Benzimidazoles; Breast Neoplasms; Cell Line, Tumor; | 2010 |
Investigations on cytotoxicity and anti-inflammatory potency of licofelone derivatives.
Topics: Animals; Anti-Inflammatory Agents; Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Cell S | 2011 |
Design and synthesis of thiourea derivatives containing a benzo[5,6]cyclohepta[1,2-b]pyridine moiety as potential antitumor and anti-inflammatory agents.
Topics: Animals; Anti-Inflammatory Agents; Antineoplastic Agents; Biological Assay; Breast Neoplasms; Cell L | 2012 |
Modulatory Effects of Metformin Alone and in Combination with Cimetidine and Ibuprofen on T Cell-related Parameters in a Breast Cancer Model.
Topics: Animals; Biomarkers; Breast Neoplasms; Cell Line, Tumor; Cimetidine; Disease Models, Animal; Female; | 2021 |
Cisplatin-cyclooxygenase inhibitor conjugates, free and immobilised in mesoporous silica SBA-15, prove highly potent against triple-negative MDA-MB-468 breast cancer cell line.
Topics: Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Cell Survival; Cisplatin; Cyclooxygenase | 2022 |
Novel Strategies against Cancer: Dexibuprofen-Loaded Nanostructured Lipid Carriers.
Topics: Breast Neoplasms; Drug Carriers; Humans; Ibuprofen; Lipids; Male; Nanostructures; Particle Size; Pol | 2022 |
Doxorubicin delivered by redox-responsive Hyaluronic Acid-Ibuprofen prodrug micelles for treatment of metastatic breast cancer.
Topics: Animals; Antibiotics, Antineoplastic; Breast Neoplasms; Cell Movement; Cell Proliferation; Disease M | 2020 |
Combination of a chemopreventive agent and paclitaxel in CD44-targeted hybrid nanoparticles for breast cancer treatment.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Cell P | 2017 |
Aspirin and ibuprofen, in bulk and nanoforms: Effects on DNA damage in peripheral lymphocytes from breast cancer patients and healthy individuals.
Topics: Adult; Aged; Aged, 80 and over; Aspirin; Breast Neoplasms; Case-Control Studies; Comet Assay; DNA Da | 2018 |
Using PVA and TPGS as combined emulsifier in nanoprecipitation method improves characteristics and anticancer activity of ibuprofen loaded PLGA nanoparticles.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Breast Neoplasms; Caco-2 Cells; Chemistry, Pharmaceu | 2017 |
Ibuprofen supports macrophage differentiation, T cell recruitment, and tumor suppression in a model of postpartum breast cancer.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Breast Neoplasms; Cell Differentiation; Female; Hu | 2018 |
Synthesis and characterization of micelles as carriers of non-steroidal anti-inflammatory drugs (NSAID) for application in breast cancer therapy.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Cel | 2014 |
Low-dose Aspirin, Nonsteroidal Anti-inflammatory Drugs, Selective COX-2 Inhibitors and Breast Cancer Recurrence.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Breast Neoplasms; | 2016 |
Ibuprofen induces reduction of the proliferation-seeking radiotracer 99mTc-(V)DMSA uptake in severe epithelial breast hyperplasia without atypia.
Topics: Breast Neoplasms; Female; Humans; Hyperplasia; Ibuprofen; Mammography; Middle Aged; Prospective Stud | 2010 |
Non-steroidal anti-inflammatory drugs (NSAIDs) and breast cancer risk: differences by molecular subtype.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Biomarkers, Tumor; Breast Neoplasms; | 2011 |
Postpartum mammary gland involution drives progression of ductal carcinoma in situ through collagen and COX-2.
Topics: Analysis of Variance; Animals; Blotting, Western; Breast Neoplasms; Carcinoma, Ductal; Celecoxib; Ce | 2011 |
Sterically stabilized liposomes incorporating the novel anticancer agent phospho-ibuprofen (MDC-917): preparation, characterization, and in vitro/in vivo evaluation.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Chemistry, P | 2012 |
Phospho-ibuprofen (MDC-917) suppresses breast cancer growth: an effect controlled by the thioredoxin system.
Topics: Animals; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Proliferation; Cell Survival; Cycl | 2012 |
By the way, doctor. I recently read that anti-inflammatory drugs reduce the risk of breast cancer. Is this true? Can you tell me anything about this?
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Breast Neoplasms; Cyclooxygenase Inhibitors; Femal | 2003 |
Breast cancer and nonsteroidal anti-inflammatory drugs: prospective results from the Women's Health Initiative.
Topics: Age Factors; Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Breast Neoplasms; Cohort Studie | 2003 |
Nonsteroidal anti-inflammatory drug use and breast cancer risk by stage and hormone receptor status.
Topics: Acetaminophen; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Bre | 2005 |
Synthesis and biological activities of novel dexibuprofen tetraacetylriboflavin conjugates.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Blood Platelets; Breast Neoplasms; C | 2007 |
NSAIDs and breast cancer recurrence in a prospective cohort study.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Breast Neoplasms; California; Chemopreventio | 2007 |
The effect of prostaglandin synthesis inhibitors and diphosphonates on tumour-mediated osteolysis.
Topics: Animals; Bone Resorption; Breast Neoplasms; Culture Techniques; Diphosphonates; Flurbiprofen; Humans | 1980 |
Regular NSAID use appears to reduce breast cancer severity.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Breast Neoplasms; Chemoprevention; Female; Humans; Ibuprofe | 1996 |
Nonsteroidal antiinflammatory drugs and breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Breast Neoplasms; | 1996 |
Effects of in vivo treatment with ibuprofen on macrophage function in breast and colon cancer patients.
Topics: Breast Neoplasms; Cell Line; Cells, Cultured; Centrifugation, Density Gradient; Colonic Neoplasms; C | 1986 |